| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $149K | -58.8% | -88.5% |
| Cost of Revenue | $126K | -45.0% | -85.8% |
| Gross Profit | $23K | -82.7% | -94.3% |
| R&D Expense | $2.5M | +5.2% | +43.3% |
| SG&A Expense | $1.7M | +5.3% | +24.3% |
| Operating Income | -$4.7M | -6.1% | -56.1% |
| Net Income | -$4.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.5M | -10.4% | +41.0% |
| Accounts Receivable | $354K | -30.5% | -61.2% |
| Inventory | $203K | — | -38.1% |
| Current Assets | $31.3M | -10.2% | +35.7% |
| Total Assets | $32.9M | -10.0% | +25.8% |
| Current Liabilities | $3.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | +18.0% | -55.4% |
| Capital Expenditures | $11K | +266.7% | +37.5% |
| Investing Cash Flow | -$11K | -266.7% | -37.5% |
| Financing Cash Flow | $1K | -97.1% | -100.0% |
| Free Cash Flow | -$3.4M | +17.8% | -55.4% |
| -8.4% |
| -54.0% |
| EPS (Basic) | -$0.27 | -8.0% | -17.4% |
| EPS (Diluted) | -$0.27 | -8.0% | -17.4% |
| -2.7% |
| +9.6% |
| Total Liabilities | $3.8M | -3.9% | -27.7% |
| Stockholders' Equity | $29.1M | -10.7% | +39.2% |